Strata Critical Medical, Inc.

SRTA

Strata Critical Medical, Inc.

SRTA

Insider Sentiment (TTM):

Last Purchase:2025-12-09Last Sale:2026-06-08Shares Purchased (TTM):22,000Shares Sold (TTM):148,487

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:55,347,675Shares Outstanding:85,322,941Institutional Ownership Pct.:64.87%

Earnings Market Reaction:

Filing Date:2026-08-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash Equivalents At Carrying Value	16	59	31	-	-	-	16	-	-	-	-	-
Cash And Cash Equivalents At Carrying Value	-	59	31	23	59	35	18	20	26	37	28	37
Restricted Cash And Cash Equivalents At Carrying V…	0	0	0	0	2	1	0	1	2	1	1	1
Accounts Receivable Net Current	43	40	40	38	28	22	20	24	28	24	21	21
Available For Sale Securities Debt Securities Curr…	6	0	30	53	55	85	109	116	116	114	138	136
Prepaid Expense And Other Assets Current	55	25	25	9	13	9	5	10	11	18	18	13
Assets Of Disposal Group Including Discontinued Op…	-	-	0	0	-	-	11	-	-	-	-	-
Assets Current	121	124	126	122	156	152	161	172	183	194	206	209
Assets Noncurrent
Property Plant And Equipment Net	41	40	36	39	34	33	28	31	22	3	3	3
Intangible Assets Net Excluding Goodwill	60	46	48	50	14	14	8	14	14	20	21	42
Goodwill	107	89	88	85	44	42	16	43	40	40	40	39
Operating Lease Right Of Use Asset	4	4	3	3	8	9	3	23	21	25	23	23
Other Assets Noncurrent	0	24	24	9	1	1	0	1	1	1	1	1
Disposal Group Including Discontinued Operation As…	-	-	0	0	-	-	41	-	-	-	-	-
Assets	333	328	325	335	258	251	257	283	280	283	295	318
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	18	20	19	27	14	11	9	16	17	11	24	19
Contract With Customer Liability Current	-	-	-	-	9	8	7	7	9	8	7	7
Operating Lease Liability Current	1	1	1	1	4	3	1	4	4	4	5	5
Liabilities Of Disposal Group Including Discontinu…	-	-	0	0	-	-	13	-	-	-	-	-
Liabilities Current	46	21	20	28	26	22	23	27	30	23	35	30
Liabilities Noncurrent
Warrants And Rights Outstanding	0	0	2	3	3	3	6	3	2	1	5	3
Operating Lease Liability Noncurrent	3	3	3	3	5	6	2	19	18	21	20	20
Deferred Income Tax Liabilities Net	0	0	0	0	0	0	0	0	0	0	0	1
Other Liabilities Noncurrent	4	17	22	18	-	-	0	-	-	-	-	-
Liabilities Of Disposal Group Including Discontinu…	-	-	0	0	-	-	4	-	-	-	-	-
Liabilities	53	42	46	52	35	31	35	49	51	46	61	55
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	433	429	425	420	411	407	407	406	402	397	390	387
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	6	3	2	4	3	3	4	2
Retained Earnings Accumulated Deficit	-154	-143	-146	-137	-194	-190	-187	-177	-175	-164	-160	-126
Stockholders Equity	279	286	279	283	223	220	222	233	229	237	234	263
Liabilities And Stockholders Equity	333	328	325	335	258	251	257	283	280	283	295	318
Allowance For Doubtful Accounts Receivable	1	1	1	-	0	0	0	0	0	0	0	0
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	2	2	2	2	2	2	2	2	2	2	2	2
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	400	400	400	400	400	400	400	400	400	400	400	400
Common Stock Shares Issued	88	87	87	86	82	81	79	78	78	77	75	74

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	18.39%	-0.56%	-5.44%	-	-	-	-	-	-	-	-	-
2025	9.83%	20.81%	9.25%	5.05%	24.52%	20.91%	-10.31%	1.65%	0.62%	-13.75%	2.50%	27.71%
2024	-15.92%	-2.79%	-0.28%	-3.69%	-9.23%	8.92%	35.24%	37.25%	10.32%	-15.51%	-3.30%	15.18%
2023	-	-	-	-18.06%	-32.20%	-44.76%	9.52%	20.07%	2.38%	34.17%	28.06%	8.27%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.64	5.93	6.38	4.39	5.95	6.96	7.07	6.32	6.04	8.35	5.81	6.87
Quick Ratio	1.45	4.71	5.13	4.08	5.44	6.53	6.87	5.97	5.67	7.56	5.31	6.45
Working Capital	75.23M	103.20M	106.40M	94.61M	130.17M	130.43M	138.02M	144.58M	152.63M	170.76M	170.77M	178.37M
Leverage & Debt
Debt to Equity	0.19	0.15	0.17	0.18	0.16	0.14	0.16	0.21	0.22	0.20	0.26	0.21
Interest Coverage TTM	-7.94	-5.79	-5.27	-1.80	-1.86	-2.84	-3.12	-6.58	-6.37	-6.20	-6.55	-6.76
Debt Ratio	0.16	0.13	0.14	0.16	0.13	0.12	0.14	0.17	0.18	0.16	0.21	0.17
Efficiency & Turnover
Asset Turnover TTM	0.87	0.79	0.68	0.39	0.40	0.49	0.53	0.68	0.79	0.76	0.73	0.67
Days Sales Outstanding TTM	51.03	49.29	55.34	93.04	94.09	63.51	50.75	40.92	38.47	31.55	25.84	27.32
Receivables Turnover TTM	7.15	7.41	6.60	3.92	3.88	5.75	7.19	8.92	9.49	11.57	14.13	13.36
Per Share Metrics
Diluted EPS TTM	0.47	0.52	0.50	0.49	-0.23	-0.33	-0.35	-0.66	-0.63	-0.66	-0.76	-0.46
Free Cash Flow Per Share TTM	-0.64	-0.68	-0.72	-0.64	-0.19	-0.25	-0.43	-0.47	-0.41	-0.44	-0.47	-0.46
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	21.25%	21.08%	20.86%	19.12%	17.67%	20.19%	20.15%	21.19%	21.43%	19.49%	18.71%	17.65%
Operating Profit Margin TTM	-7.97%	-8.59%	-11.34%	-7.70%	-9.99%	-13.97%	-15.34%	-31.89%	-27.31%	-28.16%	-30.25%	-24.17%
Net Profit Margin TTM	15.71%	20.56%	20.97%	33.20%	-17.51%	-20.24%	-18.60%	-25.35%	-20.64%	-21.66%	-24.90%	-17.40%
Growth Metrics
Net Revenue Growth (1Y)	136.11%	74.15%	34.28%	-40.07%	-54.52%	-43.29%	-34.80%	-5.95%	25.39%	40.46%	54.11%	99.88%
Net Income Growth (1Y)	-311.88%	-276.90%	-251.42%	-178.49%	-61.43%	-46.99%	-51.30%	37.03%	4.52%	89.55%	105.71%	217.01%
EPS Growth (1Y)	-299.80%	-265.64%	-242.94%	-174.29%	-63.18%	-49.71%	-53.80%	30.17%	-1.45%	80.04%	99.31%	205.58%
Valuation Metrics
P/E TTM	11.30	7.59	9.55	10.33	-17.26	-8.21	-12.06	-4.46	-5.49	-4.31	-4.63	-5.11
P/B TTM	1.63	1.25	1.41	1.47	1.47	0.99	1.48	0.98	1.18	0.91	1.11	0.73
P/S TTM	1.77	1.56	2.00	3.43	3.02	1.66	2.24	1.13	1.13	0.93	1.15	0.89
Market Cap	454.35M	356.65M	394.86M	417.22M	327.63M	218.10M	329.37M	229.45M	270.06M	216.02M	259.54M	192.02M
Enterprise Value	437.77M	297.66M	363.63M	394.20M	267.31M	182.42M	309.73M	208.04M	241.69M	177.96M	230.52M	153.75M
Calculated Values
Free Cash Flow TTM	-55.39M	-57.70M	-59.27M	-52.58M	-15.34M	-19.87M	-33.38M	-36.40M	-32.12M	-33.32M	-34.46M	-34.23M
Net Debt	-16.58M	-58.99M	-31.23M	-23.02M	-60.32M	-35.69M	-19.65M	-21.41M	-28.37M	-38.06M	-29.02M	-38.27M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-08Sale

Owner: Tomkiel, Melissa M.

Title: Co-CEO and General Counsel

Shares: 29,730

Price/Share: $5.87

Value: $174,515.10

Shares Owned: 1,892,774

Relationship: Director,Officer

Ownership: Direct

2026-06-08Sale

Owner: Wunsch, Scott M

Title: CEO, Logistics

Shares: 5,550

Price/Share: $5.87

Value: $32,578.50

Shares Owned: 625,574

Relationship: Officer

Ownership: Direct

2026-06-08Sale

Owner: Cohen, Amir

Title: Chief Accounting Officer

Shares: 4,655

Price/Share: $5.87

Value: $27,324.85

Shares Owned: 146,608

Relationship: Officer

Ownership: Direct

2026-06-08Sale

Owner: Heyburn, William A.

Title: Co-CEO and CFO

Shares: 31,671

Price/Share: $5.87

Value: $185,908.77

Shares Owned: 1,548,997

Relationship: Director,Officer

Ownership: Direct

2026-05-22Sale

Owner: Cohen, Amir

Title: Chief Accounting Officer

Shares: 40,575

Price/Share: $5.91

Value: $239,798.25

Shares Owned: 151,263

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-08	Tomkiel, Melissa M.	Director,Officer	Co-CEO and General Counsel	Direct	Sale	29,730	5.87	$174,515.10	1,892,774	4
2026-06-08	Wunsch, Scott M	Officer	CEO, Logistics	Direct	Sale	5,550	5.87	$32,578.50	625,574	4
2026-06-08	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	4,655	5.87	$27,324.85	146,608	4
2026-06-08	Heyburn, William A.	Director,Officer	Co-CEO and CFO	Direct	Sale	31,671	5.87	$185,908.77	1,548,997	4
2026-05-22	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	40,575	5.91	$239,798.25	151,263	4
2026-05-11	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	14,306	5.79	$82,831.74	202,138	4
2025-12-09	Heyburn, William A.	Director,Officer	Co-CEO and CFO	Direct	Purchase	17,000	4.47	$75,990.00	1,403,436	4
2025-12-05	Lauck, Andrew	Director	-	Direct	Purchase	5,000	4.37	$21,850.00	135,642	4
2025-11-20	Love, Reginald	Director	-	Direct	Sale	11,000	4.37	$48,070.00	113,897	4
2025-11-19	Love, Reginald	Director	-	Direct	Sale	11,000	4.31	$47,410.00	124,897	4
2025-08-04	Heyburn, William A.	Officer	Chief Financial Officer	Direct	Sale	46,918	4.94	$231,774.92	1,340,845	4
2025-08-04	Tomkiel, Melissa M.	Officer	President and General Counsel	Direct	Sale	47,995	4.94	$237,095.30	1,148,834	4
2025-06-09	Heyburn, William A.	Officer	Chief Financial Officer	Direct	Sale	100,000	4.07	$407,000.00	1,360,002	4
2025-06-09	Tomkiel, Melissa M.	Officer	President and General Counsel	Direct	Sale	100,000	4.08	$408,000.00	1,151,204	4
2025-01-07	Heyburn, William A.	Officer	Chief Financial Officer	Direct	Sale	900	5.00	$4,500.00	1,222,220	4
2024-12-13	Love, Reginald	Director	-	Direct	Sale	5,091	4.05	$20,618.55	100,363	4
2024-12-13	Borthwick, John	Director	-	Direct	Sale	78,291	4.00	$313,164.00	168,443	4
2024-12-09	Tomkiel, Melissa M.	Officer	President and General Counsel	Direct	Sale	22,486	5.01	$112,654.86	1,039,140	4
2024-12-09	Heyburn, William A.	Officer	Chief Financial Officer	Direct	Sale	39,285	5.02	$197,210.70	1,336,826	4
2024-12-04	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	5,150	4.36	$22,454.00	64,441	4
2024-11-29	Heyburn, William A.	Officer	Chief Financial Officer	Direct	Sale	23,815	5.02	$119,551.30	1,376,111	4
2024-11-29	Tomkiel, Melissa M.	Officer	President and General Counsel	Direct	Sale	22,135	5.02	$111,117.70	1,061,626	4
2024-11-14	Wiesenthal, Robert S	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	2,100,000	3.22	$6,762,000.00	4,812,892	4
2024-11-12	Tomkiel, Melissa M.	Officer	President and General Counsel	Direct	Sale	44,621	3.40	$151,711.40	1,173,003	4
2024-09-11	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	4,891	2.85	$13,939.35	74,591	4
2024-09-11	Wunsch, Scott M	Officer	CEO, Trinity Air Medical	Direct	Sale	7,741	2.85	$22,061.85	284,962	4
2024-06-10	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	11,008	3.05	$33,574.40	84,374	4
2024-06-10	Love, Reginald	Director	-	Direct	Purchase	5,091	2.99	$15,222.09	62,628	4
2024-06-10	Borthwick, John	Director	-	Direct	Purchase	7,743	2.97	$22,996.71	83,817	4
2024-04-03	Tomkiel, Melissa M.	Officer	President and General Counsel	Direct	Sale	11,734	3.28	$38,487.52	1,302,223	4/A
2024-04-03	Wiesenthal, Robert S	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	25,418	3.28	$83,371.04	7,149,493	4
2024-04-03	Heyburn, William A.	Officer	Chief Financial Officer	Direct	Sale	11,440	3.28	$37,523.20	1,413,580	4/A
2024-04-03	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	4,220	3.28	$13,841.60	95,382	4
2024-03-14	Heyburn, William A.	Officer	Chief Financial Officer	Direct	Sale	26,632	2.62	$69,775.84	1,355,020	4
2024-03-14	Bacon, Seth J	Officer	CEO, Trinity Air Medical	Direct	Sale	1,212	2.62	$3,175.44	342,381	4
2024-03-14	Wiesenthal, Robert S	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	66,932	2.62	$175,361.84	7,174,911	4
2024-03-14	Tomkiel, Melissa M.	Officer	President and General Counsel	Direct	Sale	25,634	2.62	$67,161.08	1,230,545	4
2024-03-13	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	8,057	2.69	$21,673.33	99,602	4
2023-12-15	Tomkiel, Melissa M.	Officer	President and General Counsel	Direct	Sale	6,537	3.22	$21,049.14	1,229,386	4
2023-12-15	Heyburn, William A.	Officer	Chief Financial Officer	Direct	Sale	6,793	3.22	$21,873.46	1,330,624	4
2023-12-15	Wiesenthal, Robert S	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	17,494	3.22	$56,330.68	7,264,558	4
2023-12-15	Bacon, Seth J	Officer	CEO, Trinity Air Medical	Direct	Sale	255	3.22	$821.10	84,942	4
2023-12-15	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	941	3.22	$3,030.02	99,134	4
2023-11-24	Love, Reginald	Director	-	Direct	Sale	20,000	3.21	$64,200.00	57,537	4
2023-11-13	Affeldt, Eric	Director	-	Indirect	Purchase	50,000	3.20	$160,000.00	60,000	4
2023-10-06	Heyburn, William A.	Officer	Chief Financial Officer	Direct	Sale	14,488	2.40	$34,771.20	1,367,998	4
2023-10-06	Wiesenthal, Robert S	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	37,307	2.40	$89,536.80	7,360,813	4
2023-10-06	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	2,009	2.40	$4,821.60	108,854	4
2023-10-06	Bacon, Seth J	Officer	CEO, Trinity Air Medical	Direct	Sale	553	2.40	$1,327.20	86,490	4
2023-10-06	Tomkiel, Melissa M.	Officer	President and General Counsel	Direct	Sale	13,944	2.40	$33,465.60	1,265,355	4
2023-09-13	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	10,860	3.31	$35,946.60	114,280	4
2023-07-10	Tomkiel, Melissa M.	Officer	President and General Counsel	Direct	Sale	35,623	3.88	$138,217.24	1,289,495	4
2023-07-10	Heyburn, William A.	Officer	Chief Financial Officer	Direct	Sale	32,774	3.88	$127,163.12	1,373,413	4
2023-07-07	Cohen, Amir	Officer	Chief Accounting Officer	Direct	Sale	1,541	3.82	$5,886.62	127,130	4
2023-07-06	Wiesenthal, Robert S	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	207,932	3.82	$794,300.24	7,461,564	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

64.87%

Inst. Shares: 55,347,675

Shares Outstanding: 85,322,941

2025-12-31

63.36%

Inst. Shares: 52,012,833

Shares Outstanding: 82,092,345

2025-09-30

57.16%

Inst. Shares: 47,134,328

Shares Outstanding: 82,454,657

2025-06-30

54.11%

Inst. Shares: 43,986,719

Shares Outstanding: 81,297,402

2025-03-31

52.71%

Inst. Shares: 42,107,956

Shares Outstanding: 79,891,829

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	55,347,675	85,322,941	64.87%
2025-12-31	52,012,833	82,092,345	63.36%
2025-09-30	47,134,328	82,454,657	57.16%
2025-06-30	43,986,719	81,297,402	54.11%
2025-03-31	42,107,956	79,891,829	52.71%
2024-12-31	42,658,995	77,499,423	55.04%
2024-09-30	40,479,122	78,044,254	51.87%
2024-06-30	37,551,260	77,603,604	48.39%
2024-03-31	35,043,116	75,796,411	46.23%
2023-12-31	33,581,613	73,524,476	45.67%
2023-09-30	33,050,623	74,139,422	44.58%
2023-06-30	36,006,115	73,169,003	49.21%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Strata Critical Medical, Inc. (SRTA) — SEC Financial Statements & Analysis

Strata Critical Medical, Inc. (SRTA) is a services-health services company, incorporated in DE. Strata Critical Medical, Inc. trades on Nasdaq as: SRTA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Strata Critical Medical, Inc. reported a 136.11% year-over-year revenue growth, a Gross Profit Margin of 21.25% (TTM), a Debt-to-Equity ratio of 0.19x, a Price-to-Sales (P/S) ratio of 1.77x (TTM), a Price-to-Book (P/B) ratio of 1.63x (TTM), at a market cap of $454.35M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 136.11%
Gross Profit Margin TTM: 21.25%
Debt To Equity: 0.19x
P/S TTM: 1.77x
P/B TTM: 1.63x
Market Cap: $454.35M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Strata Critical Medical, Inc. in?

Strata Critical Medical, Inc. (SRTA) operates in the Services-Health Services industry.

What is SRTA's market cap?

Strata Critical Medical, Inc. (SRTA) has a market capitalization of $454.35M as of 2026-06-30.

What is SRTA's P/E ratio?

Strata Critical Medical, Inc. (SRTA)'s trailing twelve month P/E ratio is 11.30x as of 2026-06-30.

What exchange does SRTA trade on?

Strata Critical Medical, Inc. (SRTA) trades on the Nasdaq.

Where is Strata Critical Medical, Inc. incorporated?

Strata Critical Medical, Inc. is incorporated in DE.